Source: THE STAR

Aryogen: Malaysian-made biosimilar products to be sold in Asean

KUALA LUMPUR: Inno Bio Ventures Sdn Bhd and Aryogen Biopharma have inked an MoU to market and distribute locally-made biosimilar products in Asean countries.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Mohammad Saffarioun's photo - CEO of AryoGen Pharmed

CEO

Mohammad Saffarioun

CEO Approval Rating

67/100

Read more